Treatment and progress of post thrombotic syndrome

doi:10.3877/cma.j.issn.1674-0793.2019.01.017

Abstract

Abstract:

Post thrombosis syndrome (PTS) is a long-term sequelae of deep venous thrombosis (DVT). Even if DVT is given standardized anticoagulant therapy at an early stage, there is still a high incidence of PTS. Deep venous valve injury reflux, increased venous pressure, and blocked venous blood flow are considered to be the main formation mechanisms of PTS. Traditional PTS treatments include anticoagulant therapy, elastic compression socks, exercise therapy, and drug therapy. Percutaneous angioplasty and dedicated venous stents to treat PTS have achieved good results and have been widely accepted clinically. This article reviews the clinical diagnosis and treatment of PTS in order to further guide the clinical treatment.

Key words: Postthrombotic syndrome, Angioplasty, balloon, Stents, Prosthesis implantation

Liling Sun. Treatment and progress of post thrombotic syndrome[J]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(01): 76-80.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2019.01.017

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2019/V13/I01/76

References 44

[1]	Kahn SR, Galanaud JP, Vedantham S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome[J]. J Thromb Thrombolysis, 2016, 41(1): 144-153.
[2]	Rabinovich A, Kahn SR. The postthrombotic syndrome: current evidence and future challenges[J]. J Thromb Haemost, 2017, 15(2): 230-241.
[3]	Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): 737-801.
[4]	Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association[J]. Circulation, 2014, 130(18): 1636-1661.
[5]	Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
[6]	Tan M, Mos IC, Klok FA, et al. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review[J]. Br J Haematol, 2011, 153(2): 168-178.
[7]	Vedantham S. Knowns and unknowns in managing postthrombotic syndrome[J]. Semin Intervent Radiol, 2017, 34(1): 68-72.
[8]	Farrell JJ, Sutter C, Tavri S, et al. Incidence and interventions for post-thrombotic syndrome[J]. Cardiovasc Diagn Ther, 2016, 6(6): 623-631.
[9]	Bharath V, Kahn SR, Lazo-Langner A, et al. Genetic polymorphisms of vein wall remodeling in chronic venous disease: an arrativeand systematic review[J]. Blood, 2014, 124(8): 1242-1250.
[10]	Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study[J]. Arch Intern Med, 2001, 161: 2105-2109.
[11]	Rabinovich A, Kahn SR. How to predict and diagnose postthrombotic syndrome[J]. Pol Arch Med Wewn, 2014, 124(7-8): 410-416.
[12]	Milan M, Sarolo L, Callegari E, et al. High rate of inter-observer agreement between professional-rated scores of the Villalta scalefor the assessment of the post-thrombotic syndrome[J]. Thromb Res, 2016, 144: 182-183.
[13]	Jayaraj A, Meissner MH. A comparison of Villalta-Prandoni scale and venous clinical severity score in the assessment of post thrombotic syndrome[J]. Ann Vasc Surg, 2014, 28(2): 313-317.
[14]	Blomgren L, Engström J, Rosfors SA, et al. comparison of magnetic resonance venography findings and venous occlusion plethysmography variables in postthrombotic syndrome[J]. Vascular, 2017, 25(4): 406-411.
[15]	Liu D, Peterson E, Dooner J, et al. Diagnosis and managementof iliofemoral deep vein thrombosis: clinical practice guideline[J]. CMAJ, 2015, 187(17): 1288-1296.
[16]	Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2): 278-325.
[17]	Kearon C, Akl EA, Comerota AJ, et al. Antithrombotictherapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2): 419-494.
[18]	Hull RD, Townshend G. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence[J]. Thromb Haemost, 2013, 110(1): 14-22.
[19]	Carman TL. Prevention of the post-thrombotic syndrome[J]. Curr Treat Options Cardiovasc Med, 2016, 18(8): 51.
[20]	Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: ACCP evidence-based clinical practice guidelines (8th edition)[J]. Chest, 2008, 133(6): 454-545.
[21]	Berntsen CF, Kristiansen A, Akl EA, et al. Compression stockings for preventing the postthrombotic syndrome in patients with deepvein thrombosis[J]. Am J Med, 2016, 129(4): 447.
[22]	Diehm N. Compression stockings can not prevent post-thrombotic syndrome[J]. MMW Fortschr Med, 2014, 156(4): 33.
[23]	Kanaan A. Elastic compression stockings fail to prevent post-thrombotic syndrome after a first deep vein thrombosis[J]. Evid Based Nurs, 2015, 18(1): 22.
[24]	Rabe E, Partsch H, Hafner J, et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement[J]. Phlebology, 2018, 33(3): 163-184.
[25]	Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial[J]. Lancet, 2014, 383(9920): 880-888.
[26]	Padberg FT Jr, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial[J]. J Vasc Surg, 2004, 39(1): 79-87.
[27]	Cohen JM, Akl EA, Kahn SR. Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials[J]. Chest, 2012, 141(2): 308-320.
[28]	Vazquez SR, Freeman A, VanWoerkom RC, et al. Contemporary issues in the prevention and management of postthrombotic syndrome[J]. Ann Pharmacother, 2009, 43(11): 1824-1835.
[29]	Baldwin MJ, Moore HM, Rudarakanchana N, et al. Post-thrombotic syndrome: a clinical review[J]. J Thromb Haemost, 2013, 11(5): 795-805.
[30]	Khanna AK, Singh S. Postthrombotic syndrome: surgical possibilities[J]. Thrombosis, 2012: 520604.
[31]	Busuttil A, Lim CS, Davies AH. Post thrombotic syndrome[J]. Adv Exp Med Biol, 2017, 906: 363-375.
[32]	Kahn SR. The post-thrombotic syndrome[J]. Hematology Am Soc Hematol Educ Program, 2016: 413-418.
[33]	Wen-da W, Yu Z, Yue-Xin C. Stenting for chronic obstructive venous disease: A current comprehensive meta-analysis and systematic review[J]. Phlebology, 2016, 31(6): 376-389.
[34]	Raju S. Treatment of iliac-caval outflow obstruction[J]. Semin Vasc Surg, 2015, 28(1): 47-53.
[35]	Seager MJ, Busuttil A, Dharmarajah B, et al. Editor's choice--a systematic review of endovenous stenting in chronic venous disease secondary to iliac vein obstruction[J]. Eur J Vasc Endovasc Surg, 2016, 51(1): 100-120.
[36]	Falcoz MT, Falvo N, Aho-Glélé S, et al. Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement[J]. Quant Imaging Med Surg, 2016, 6(4): 342-352.
[37]	Jeraj L, Jezovnik MK, Poredos P. Insufficient recanalization of thrombotic venous occlusion-risk for postthrombotic syndrome[J]. J Vasc Interv Radiol, 2017, 28(7): 941-944.
[38]	de Wolf MA, de Graaf R, Kurstjens RL, et al. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent[J]. Eur J Vasc Endovasc Surg, 2015, 50(4): 518-526.
[39]	Jalaie H, Arnoldussen C, Barbati M, et al. What predicts outcome after recanalization of chronic venous obstruction: hemodynamicfactors, stent geometry, patient selection, anticoagulation or other factors?[J]. Phlebology, 2014, 29(1 suppl): 97-103.
[40]	Roy M, Sasson M, Rosales-Velderrain A, et al. Pharmacomechanical thrombolysis for deep vein thrombosis in May-Thurner syndrome[J]. Innovations (Phila), 2017, 12(6): 466-471.
[41]	Lee KA, Ramaswamy RS. Interventional approaches to deep venous thrombosis[J]. Curr Opin Cardiol, 2017, 32(6): 679-686.
[42]	Jalaie H, Schleimer K, Barbati ME, et al. Interventional treatment of postthrombotic syndrome[J]. Gefasschirurgie, 2016, 21(Suppl 2): 37-44.
[43]	Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and Meta-analysis[J]. Circ Cardiovasc Interv, 2015, 8(10): e002772.
[44]	中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第2版)[J]. 中华外科杂志, 2012, 50(7): 611-614.

Please choose a citation manager

Content to export